Gilteritinib is a FLT3 inhibitor. It’s approved for treating relapsed or tough AML in folks who have FLT3 mutations. It works by blocking the FLT3 kinase.
This stops leukemia cells from growing. You can get it in 40 mg film-coated tablets. Doctors usually suggest 120 mg taken once every day by mouth.
It comes in bottles with 90 pills.
Reviews
There are no reviews yet.